Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-11

Clinical Trial Update: Evaluation of Intravenous Cardene(Nicardipine)and Labetalol Use in the Emergency Department [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated intravenous nicardipine (Cardene) and labetalol for hypertensive urgency in the emergency department. The study completed and posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cardene (nicardipine)
  • labetalol (labetalol hydrochloride)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Hypertensive Urgency | Phase 4 | Status: COMPLETED | Results posted: 2014-12-11